Advertisement
Trending - Altmetric
-
Osimertinib and palbociclib in an EGFR-mutated NSCLC with primary CDK4 amplification after progression under osimertinib
-
Prediction of TKI response in EGFR-mutant lung cancer patients-derived organoids using malignant pleural effusion
-
Quantification of cerebrospinal fluid tumor DNA in lung cancer patients with suspected leptomeningeal carcinomatosis
-
Acquired resistance to immunotherapy and chemoradiation in MYC amplified head and neck cancer